Skip to main content

Table 1 Data summary in patients receiving SERMs

From: Selective estrogen receptor modulators and deep venous thrombosis after an emergent operation in senior women

 

Ultrasound examination for lower extremities

SERM

Age (years)

Height (cm)

Weight (kg)

Disease

Operation

Anesthesia

Before operation

After operation

Raloxifene

83

141

36

Fracture of the left tibia

ORIF

General

DVT ( −)

DVT ( −)

Raloxifene

78

147

41.8

Periprosthetic infection (left hip)

Debridement

General

DVT ( −)

DVT ( −)

Raloxifene

79

148

40

Periprosthetic infection (left hip)

Debridement

General

DVT ( −)

DVT ( −)

Raloxifene

94

150

49.8

Fracture of the neck of the right femur

Osteosynthesis

Spinal

DVT ( −)

DVT in the left soleal vein

Raloxifene

86

158

46.9

Fracture of the neck of the right femur

Artificial head replacement

General

DVT ( −)

DVT ( −)

Bazedoxifene

86

152

55.5

Fracture of the neck of the left femur

Osteosynthesis

General

DVT ( −)

DVT ( −)

Bazedoxifene

85

146

54.3

Periprosthetic infection (right knee)

Debridement

General

DVT in the left soleal vein

DVT in the right and the left soleal vein and the right femoral vein

Bazedoxifene

74

154

72

Fracture of the neck of the right femur

Artificial head replacement

General

DVT (-)

DVT ( −)

  1. SERMs selective estrogen receptor modulators, DVT deep venous thrombosis, ORIF open reduction and internal fixation